Rajeev Raghuvanshi Appointed as New Drug Controller General of India: Rajeev Singh Raghuvanshi is the next Drug Controller General of India (DCGI), Central Drugs Standard Control Organization (CDSCO). Rajeev Singh Raghuvanshi is a former secretary-cum-scientific director of the Indian Pharmacopoeia Commission. Rajeev Singh Raghuvanshi will succeed Dr. PBN Prasad, who will serve until February 28th, 2023. The order which was released stated that Raghuvanshi will continue to be the DGCI till February 28, 2025.
February 2023 Current Affairs Quiz
Rajeev Raghuvanshi Appointed as New Drug Controller General of India- Key Points
- His name has been suggested to the government by the Union Public Service Commission (UPSC) as the successor to Dr. V G Somani, whose extended tenure would end in mid-February.
- The recommendation was later confirmed by the Health Ministry, and then by the Appointments Committee of the Cabinet, which is overseen by Prime Minister Narendra Modi.
- Based on the assessment of bio-data of the eligible officers received and after holding personal talks with them on January 27 recommends Dr. Rajeev Singh Raghuvanshi for appointment to the post of Drug Controller (India) on a short-term contract basis.
- The DCGI is in charge of the Central Drugs Standard Control Organization (CDSCO), which is in responsibility of assuring quality drug supply throughout the country.
- It also has the authority to give approval to new drugs and regulate clinical trials.
- Dr. Raghuvanshi holds 14 US patents, as well as over 250 published patent cooperation treaties and Indian patents.
- He has more than 25 publications in peer-reviewed journals and has co-authored six chapters in books.
